At a meeting on May 16, the government plans to reopen discussions with industry stakeholders on the divisive subject of trade margin rationalisation (TMR) on drugs and medical devices.
Members of pharmaceutical associations and makers of medical devices were invited to the meeting in this respect by the Department of Pharmaceuticals (DoP) and the National Pharmaceutical Pricing Authority (NPPA), who also requested suggestions by Friday.
“The DoP and NPPA have been receiving various suggestions from the industry for amendments in DPCO, 2013 and National Pharmaceutical Pricing Policy. Hence, it has been decided to organise a workshop with industry stakeholders with the participation of the associations of pharma and the medical device sector,” said the invite.
The lobby group members are anticipated to start the conversation of implementing TMR on pharmaceutical formulations. The government should implement the “one-molecule, one-price” formula, according to several small and medium-sized pharmaceutical companies.